2025-04-01 12:34:08
Latest Post
KEC International wins New Orders of Rs. 1,236 crores
Newgen Software Technologies Ltd receives order worth Rs. 17.51 crore
Salila Pande Takes Charge as the MD & CEO of SBI Card
Mishra Dhatu Nigam Ltd - Performance Highlights FY 2024- 25
Bright Completes Two Bright Years on BSE: A Journey of Excellence, Innovation & Digital Transformation
Stock Report
Ind-Swift Laboratories Ltd posts consolidated PAT of Rs. 25.34 crores in Q2FY23
Posted On : 2022-11-09 07:09:38( TIMEZONE : IST )
Ind-Swift Laboratories Limited has reported Consolidated financial results for the period ended September 30, 2022.
Financial Results (Q2 FY2023) - QoQ Comparison
The company has reported total income of Rs. 317.7553 crores during the period ended September 30, 2022 as compared to Rs. 287.5582 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. 25.3430 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 19.8793 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. 4.29 for the period ended September 30, 2022 as compared to Rs. 3.36 for the period ended June 30, 2022.
| Financials | Q2 FY2023 | Q1 FY2023 | % Change |
| Total Income | ₹ 317.7553 crs | ₹287.5582 crs |  10.50% |
| Net Profit | ₹25.3430 crs | ₹19.8793 crs | 27.48% |
| EPS | ₹4.29 | ₹3.36 | 27.68% |
Financial Results (Q2 FY2023) - YoY Comparison
The company has reported total income of Rs. 317.7553 crores during the period ended September 30, 2022 as compared to Rs.242.7898 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.25.3430 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.24.4705 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.4.29 for the period ended September 30, 2022 as compared to Rs.4.14 for the period ended September 30, 2021.
| Financials | Q2 FY2023 | Q2 FY2022 | % Change |
| Total Income | ₹ 317.7553 crs | ₹242.7898 crs | 30.88% |
| Net Profit | ₹25.3430 crs | ₹24.4705 crs | 3.57% |
| EPS | ₹4.29 | ₹4.14 | 3.62% |
Financial Results (Half Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.605.3136 crores during the 6 Months period ended September 30, 2022 as compared to Rs.498.5420 crores during the 6 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.45.2223 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.43.2747 crores for the 6 Months period ended September 30, 2021.
The company has reported EPS of Rs.7.65 for the 6 Months period ended September 30, 2022 as compared to Rs.7.32 for the 6 Months period ended September 30, 2021.
| Financials | Half Year Ended FY2023 | Half Year Ended FY2022 | % Change |
| Total Income | ₹605.3136 crs | ₹498.5420 crs | 21.42% |
| Net Profit | ₹45.2223 crs | ₹43.2747 crs | 4.50% |
| EPS | ₹7.65 | ₹7.32 | 4.51% |
Shares of Ind-Swift Laboratories Limited was last trading in BSE at Rs. 54.10 as compared to the previous close of Rs. 53.85. The total number of shares traded during the day was 3873 in over 157 trades.
The stock hit an intraday high of Rs. 55.30 and intraday low of 53.45. The net turnover during the day was Rs. 209656.00.
